Introduction
Epilepsy is the third most common neurological disorder in old age after dementia and stroke. 1 The elderly population is increasing rapidly, more than 20% of the world population will be over 60 years of age by 2050, 2 therefore the prevalence of epilepsy in old age will increase and should be regarded as a significant public health issue as well as an important clinical problem.
There is a rise in the incidence of epilepsy in the early years of life and a second more marked rise in those 60 years of age and above; older people are now the group with the highest incidence of epilepsy in the general population. 3, 4, 5 It is now a common occurrence for the older patient to present with epilepsy in general practice. 6 The Rochester Minnesota survey found that both single unprovoked seizures and epilepsy increased sharply with age. 7 The active prevalence rate of epilepsy among persons over 65 is approximately 1.5%, about twice the rate in younger adults. 8 Despite this considerable public health need, there are fewer academic publications concerning epilepsy and its treatment in older people than other age groups and much less is known about many aspects of care. In this United Kingdom (UK) general practice notes review we present data on an unselected community based cohort that primarily looks at; seizure frequency, drug treatment, diagnostic referral patterns and continuing care referral patterns.
The paper mentions and presents data on, among others, services provided by both general practitioners and general physicians in the UK. For clarification, within the UK National Health Service general physicians work in hospital (secondary care) with those between the ages of 16-75 and general practitioners in community care (primary care) throughout the whole age range. Even though referred to as ''generalists'' the physicians in secondary care would be regarded as having more specialised knowledge and general practitioners refer on to the physicians where it is thought applicable.
Aim:
To ascertain present United Kingdom (UK) management processes for epilepsy in older people. Method: This was a general practice notes review of people being treated for epilepsy 60 years and over. Results: The cohort of 110 was from six practices. Seizure frequency in older people with epilepsy appears lower than in general; 75% are seizure free. This compares with 40-60% of people in other general practice note reviews and audits, where age is not a factor. Out of the people still having seizures over half have less than one seizure per month.
Monotherapy rates are similar to the population in general. Nobody was taking more than two AEDs. There is evidence of new AED use, especially lamotrigine; it is the most commonly prescribed AED in those diagnosed in later life.
Geriatricians appear to receive virtually no referrals for the diagnosis of epilepsy. General physicians, psychiatrists and neurologists receive many more. Geriatricians and general physicians appear never to follow up older people with epilepsy; GPs following up 91%, and neurologists and specialist nurses 9%. Conclusions: Seizure frequency in older people with epilepsy is generally low. Geriatricians appear to receive virtually no referrals for the diagnosis or management of epilepsy in older people. Follow up is mainly undertaken by GPs. Although lamotrigine has a difficult dosing schedule, which may be confusing for some older people, its use is high perhaps reflecting recent guidelines and evidence.
These results may be peculiar to the geographical area used, so other work is needed to confirm or refute these findings.
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Methodology
An audit data sheet was initially designed by adapting the protocol used by Chappell and Hall in their previous review of general practice epilepsy care that had no age limits. 9 After visits to two general practices that involved looking at data on computer and in patient notes this was then updated to reflect the basic data on epilepsy in older people that was likely to be available in a group of practices. Ten general practices were approached and asked if they were willing to take part in the review.
The letter of invitation explained: the main aim of the review, namely to consider the present care for people 60 years of age and over with epilepsy; that an adapted previously designed data collection sheet would be followed and that practices could either collect their own data or one of the research team would support them in the collection of their data.
Six practices opted to take part and all decided that they would welcome support in collecting the data.
Data was collected over a period of three months, entered into SPSS for Windows 14.0 and analysed.
Results

Background information for full cohort (N = 110)
Age (N = 110) ( Table 1 )
Fifty six (51%) were male and 54 (49%) were female.
Age at diagnosis (N = 90) ( Table 2) Who made the diagnosis (N = 52) For people diagnosed in childhood (therefore by definition diagnosed many years ago) the correspondence pertaining to this in patient notes was either impossible to find or non-specific about who did what, hence the absence of paediatricians in the data (Table 3) .
Seizure frequency per annum (N = 93) ( Table 4) Number of AEDs being taken (N = 110)
Fourteen people (13%) were taking no AEDs, 76 (69%) were taking one and 20 (18%) were taking two.
Name of AEDs being taken (N = 110)
When combining monotherapy and polytherapy the most commonly used AEDs were phenytoin (N = 37), sodium valproate (N = 29) and lamotrigine (N = 15) ( Table 5 ). Who follows people up (N = 103) Ninety four (91%) were being followed up by their GP, 4 (4%) by a neurologist and 5 (5%) by a specialist epilepsy nurse.
Date of the person's last visit to the general practice surgery for their epilepsy (N = 88) ( Table 6) Those diagnosed at 60 years of age or above (N = 37)
The age range of this sub-cohort was 64-91 years. There were more males (22 [60%]) than females (15 [40%] ).
Who made the diagnosis (N = 27) Table 7 shows who made the diagnosis.
Seizure frequency per annum (N = 34) Twenty seven (79%) were seizure free and only two (6%) had more than one seizure per month. There was no record of seizure frequency in the notes for three people.
Number of AEDs being taken (N = 37)
Three people (8%) were taking no AEDs, 27 (73%) were taking one and 7 (19%) were taking two.
Names of the AEDs being taken (N = 37)
When combining monotherapy and polytherapy the most commonly used AEDs were lamotrigine (N = 11), sodium valproate (N = 10) and phenytoin (N = 9) ( Table 8 ).
Who follows people up (N = 35)
Twenty nine (84%) were being followed up by their GP, 3 (8%) by a neurologist and 3 (8%) by a specialist epilepsy nurse.
Discussion
This cohort of people 60 years and over with epilepsy was both typical and untypical when compared with epilepsy cohorts of all age groups recruited from UK general practice note reviews and audits. The split between the sexes and the use of monotherapy was virtually identical. 9, 10 Whereas seizure frequency was much lower suggesting that seizures are easier to treat in older people. 9, 10 Three quarters were seizure free (79% in those diagnosed 60 and over) and of those still having seizures over half had less than one seizure per month. This is interesting, as it is fair to assume that for those in the cohort whose epilepsy developed in later life that it would be either symptomatic or cryptogenic and therefore normally associated with being difficult to treat. AED use was quite unusual; notably the very low number of people taking carbamazepine. As carbamazepine is an enzyme inducing AED 11 you can argue that it is more difficult to use in those highly likely to be taking other non-epilepsy medications.
There was evidence of the use of newer AEDs launched since 1989, especially lamotrigine. In fact, lamotrigine was the most commonly used AED in those diagnosed at age 60 or over. We can provide no direct insight from the physicians involved into why this might be, but it is very different from what you would find in those diagnosed before 60 years of age. 10, 12 Lamotrigine is not the easiest AED to introduce and it could be argued that it might be quite a challenge for some older people to follow the complex initial dosage regime. The recent SANAD study (covering partial [focal] seizures), plus earlier data and guidelines support the use of lamotrigine in older people, [13] [14] [15] [16] but despite this it is overall usage did seem a little high. Fourteen people were not taking AEDs. Some practices had epilepsy databases, but some did not and it is possible that there were more people with epilepsy not being treated as some practices identified their patients by searching prescriptions (both computer generated and handwritten). We obtained limited data for this group. All were being followed up by their GP. Their age range was 62-84 years. We only had seizure frequency data for eight. Six of the eight were seizure free, but two people were having up to one seizure per month. It is interesting that two people did not opt for treatment. We do not know specifically why, but there are logical reasons for this in older people, i.e. they may not be able to drive for other reasons or want to work, etc., therefore seizure freedom, unlike many younger people, might not be their ultimate goal? Twenty one people (19%) were taking phenytoin montherapy. In modern practice this may seem high. It was mainly explained by 17 (90%) people who were diagnosed quite a long time ago. Also, 17 of the 21 (90%) were seizure free, a higher figure than the cohort's seizure freedom in general; so a policy of ''leave well alone'' has probably been judicious.
Perhaps the most remarkable part of the note review was the organization of care. Interestingly the National Institute for Clincal Excellence (NICE) guidelines 17 do not include a specific advisory section for older people, even though epilepsy is common in this age group. 18 Arguably the most important statement in the guideline was as follows: ''The Guideline Development Group (GDG) felt strongly that older people with epilepsy should have access to the same range of investigations and treatment as any other group with epilepsy.'' 17 The data in this study would suggest that care for older people differs dramatically from other age groups, therefore not fulfilling the NICE advice.
17 This is at its most notable when compared with children. Previous work suggests that the vast majority of children are diagnosed and regularly followed up by specialist staff (paediatricians), 19 whereas in this older age group only one person was diagnosed and nobody at all was being followed up by specialist staff particular to the age group (geriatricians), although 9% did continue to see a neurologist or specialist nurse, both these latter professionals groups, of course, being very applicable for this group of people's care. As 25% of people continued to have seizures and 9% were being seen by ''specialist care'' this means approximately two thirds of people still having seizures were being solely managed by their GP. All the people who were initially seen by a general physician are not being followed up by the same service at all. Why should GPs be deemed skilled to follow up people 60 and over, when they are obviously not deemed the same for children and adolescents? Is epilepsy easier to manage in older people? Tallis certainly thinks not. 20 In his paper he outlines the particular difficulties of diagnosis, choice of AED and advice about lifestyle. We agree with this. Yes, there is the argument that seizure frequency would appear to be lower, therefore management simpler, but this is not looking at the full picture and impact. Surely, the complexities of epilepsy itself and living with epilepsy in this age group dictate that more than 9% of people will need specialist follow up?
The new General Medical Services (GMS) contract outlined some standards for managing people with epilepsy in general practice. 21 The standards were not ambitious. One standard stated that all people with epilepsy should be reviewed within any 15 month period. Eighty-six percent of this cohort met this standard. We do not have any detail of what actually happened at these reviews, but it is encouraging that such a large percent had been seen.
Conclusion
Seizure frequency in older people with epilepsy is generally low; 75% being seizure free. Of those still having seizures over half have less than one seizure per month.
In our study geriatricians appear to receive virtually no referrals for the diagnosis of epilepsy, despite there being a specialist epilepsy clinic for older people available within a reasonable travelling distance. Psychiatrists, neurologists (very applicable) and most notably general physicians receive the vast majority of referrals. Also, geriatricians appear not to follow up older people with epilepsy; the vast majority of this work is completed by GPs, which varies dramatically from children with epilepsy.
AED use is different, especially for lamotrigine and carbamazepine.
It should be noted that the organization of care results maybe peculiar to the geographical area used, so other work is needed to confirm or refute these findings.
